azintamide

그림문자(GHS)

• 그림문자(GHS)

  

• 신호 어

  Warning

• 유해·위험 문구

  H302：삼키면 유해함

• 예방조치문구

  P264：취급 후에는 손을 철저히 씻으시오.

  P264：취급 후에는 손을 철저히 씻으시오.

  P270：이 제품을 사용할 때에는 먹거나, 마시거나 흡연하지 마시오.

  P301+P312：삼켜서 불편함을 느끼면 의료기관(의사)의 진찰을 받으시오.

  P330：입을 씻어내시오.

  P501：...에 내용물 / 용기를 폐기 하시오.

azintamide 화학적 특성, 용도, 생산

• Originator

  Azintamide,Bristhar Laboratorios

• Manufacturing Process

  7.3 parts of 3-chloro-6-mercaptopyridazine are neutralised with 20 parts of 10% caustic soda solution, diluted with 60 parts of 50% ethanol, and heated to 60°C. 7.5 parts of chloroacetic acid diethyl amide dissolved in 20 parts of ethanol are added to this solution over a period of 10 min and the resulting mixture is heated to 60°C for 30 min. The reaction solution is then cooled, the resulting crystallisate is removed by suction, and the filtrate is extracted with ethyl acetate. The solvent is removed by evaporation and the concentration residue is combined with the crystallisate. After two recrystallisations from benzene, 11 parts of 3-chloro-pyridazine-6-mercaptoacetic acid diethyl amide, having a melting point of from 139° to 140°C are yielded.

• Therapeutic Function

  Choleretic

azintamide 준비 용품 및 원자재

azintamide 공급 업체

Global(51)Suppliers